Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hai-Bo Liu

Showing results (131-140 of 187) with videos related to

Pageof 19
Sort By:
Chinese Medical Journal|February 4, 2006
Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteriesJi-lin Chen, Run-lin Gao, Yue-jin Yang, et al.
Coronary Artery Disease|October 17, 2008
Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stentJue Chen, Jian-Jun Li, Ji-Lin Chen, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|January 13, 2009
[Outcome of patients implanted with bioabsorbable polymer sirolimus-eluting stent (Excel) and the durable polymer sirolimus-eluting stent (Cypher)]Zhan GAO, Yue-jin YANG, Ji-lin CHEN, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|August 23, 2007
[Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis]Ji-Lin Chen, Yue-Jin Yang, Shu-Bin Qiao, et al.
Zhonghua Yi Xue Za Zhi|December 3, 2005
[Short and long-term therapeutic effects of rapamycin-eluting stent and paclitaxel-eluting stent in treatment of coronary disease with complicated lesions]Ji-lin Chen, Run-lin Gao, Yue-jin Yang, et al.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|April 20, 2007
Comparison of short- and long-term outcomes between Cypher and TAXUS drug-eluting stents for in-stent restenosisJi-Lin Chen, Yue-Jin Yang, Shu-Bin Qiao, et al.
Carcinogenesis|January 21, 2016
PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinomaLi-Yi Zhang, Jian-Lin Wu, Hai-Bo Qiu, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|June 3, 2005
[The influence of diabetes mellitus on the procedural and in-hospital outcomes after selective percutaneous coronary intervention]Chong-jian Li, Run-lin Gao, Ji-lin Chen, et al.
Zhonghua Nei Ke Za Zhi|September 25, 2003
[Complications in selective percutaneous coronary interventions: analysis of 2,868 cases]Meng-yue Yu, Run-lin Gao, Ji-lin Chen, et al.
Chinese Medical Journal|February 21, 2015
Impact of body mass index on the clinical outcomes after percutaneous coronary intervention in patients ≥ 75 years oldPei-Yuan He, Yue-Jin Yang, Shu-Bin Qiao, et al.
Pageof 19

Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
Chinese Medical Journal|February 4, 2006
Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteriesJi-lin Chen, Run-lin Gao, Yue-jin Yang, et al.
Coronary Artery Disease|October 17, 2008
Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stentJue Chen, Jian-Jun Li, Ji-Lin Chen, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|January 13, 2009
[Outcome of patients implanted with bioabsorbable polymer sirolimus-eluting stent (Excel) and the durable polymer sirolimus-eluting stent (Cypher)]Zhan GAO, Yue-jin YANG, Ji-lin CHEN, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|August 23, 2007
[Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis]Ji-Lin Chen, Yue-Jin Yang, Shu-Bin Qiao, et al.
Zhonghua Yi Xue Za Zhi|December 3, 2005
[Short and long-term therapeutic effects of rapamycin-eluting stent and paclitaxel-eluting stent in treatment of coronary disease with complicated lesions]Ji-lin Chen, Run-lin Gao, Yue-jin Yang, et al.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|April 20, 2007
Comparison of short- and long-term outcomes between Cypher and TAXUS drug-eluting stents for in-stent restenosisJi-Lin Chen, Yue-Jin Yang, Shu-Bin Qiao, et al.
Carcinogenesis|January 21, 2016
PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinomaLi-Yi Zhang, Jian-Lin Wu, Hai-Bo Qiu, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|June 3, 2005
[The influence of diabetes mellitus on the procedural and in-hospital outcomes after selective percutaneous coronary intervention]Chong-jian Li, Run-lin Gao, Ji-lin Chen, et al.
Zhonghua Nei Ke Za Zhi|September 25, 2003
[Complications in selective percutaneous coronary interventions: analysis of 2,868 cases]Meng-yue Yu, Run-lin Gao, Ji-lin Chen, et al.
Chinese Medical Journal|February 21, 2015
Impact of body mass index on the clinical outcomes after percutaneous coronary intervention in patients ≥ 75 years oldPei-Yuan He, Yue-Jin Yang, Shu-Bin Qiao, et al.
Pageof 19